Clinical Trial Update: Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing whether high-oleic canola oil and flaxseed oil reduce cholesterol and other cardiovascular risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Flaxseed oil (linseed oil)
• High-oleic canola oil

Snippet

Sponsor: University of Manitoba | Conditions: Cardiovascular Disease | Phase 2 | Status: COMPLETED